Pituitary ACTH Hypersecretion (Cushing’s Disease)

Posted on October 10, 2015 by MaryO

Browse Complete Report with TOC:

http://www.reportbazzar.com/product/pituitary-acth-hypersecretion-cushings-disease-pipeline-review-h1-2015/

Summary

This report provides comprehensive information on the therapeutic development for Pituitary ACTH Hypersecretion (Cushing’s Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pituitary ACTH Hypersecretion (Cushing’s Disease) and special features on late-stage and discontinued projects.

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Request Sample Report:  Pituitary ACTH Hypersecretion (Cushing’s Disease) – Pipeline Review, H1 2015

Scope

– The report provides a snapshot of the global therapeutic landscape of Pituitary ACTH Hypersecretion (Cushing’s Disease)

– The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved in the therapeutics development for Pituitary ACTH Hypersecretion (Cushing’s Disease) and enlists all their major and minor projects

– The report summarizes all the dormant and discontinued pipeline projects

– A review of the Pituitary ACTH Hypersecretion (Cushing’s Disease) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

– Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– A detailed assessment of monotherapy and combination therapy pipeline projects

– Coverage of the Pituitary ACTH Hypersecretion (Cushing’s Disease) pipeline on the basis of target, MoA, route of administration and molecule type

– Latest news and deals relating related to pipeline products

Reasons to buy

– Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Develop strategic initiatives by understanding the focus areas of leading companies

– Identify and understand important and diverse types of therapeutics under development for Pituitary ACTH Hypersecretion (Cushing’s Disease)

– Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

– Devise corrective measures for pipeline projects by understanding Pituitary ACTH Hypersecretion (Cushing’s Disease) pipeline depth and focus of Indication therapeutics

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline”

 

 

From http://www.medgadget.com/2015/10/pituitary-acth-hypersecretion-cushings-disease-pipeline-review-h1-2015-by-reportbazzar.html

Filed under: Clinical trials, Cushing's, pituitary, Treatments | Tagged: , , , , | Leave a comment »

Hollywood actor, 42, is trapped in a 14-year-old body and loves it

Posted on October 3, 2015 by MaryO

Mario Bosco’s memoir entitled ‘From Hopeless to Hollywood: The Mario Bosco Story,’ which came out in July, details how his condition that makes him small helped him to land a Hollywood career.

He spent his childhood being bullied by his peers for his small frame and as he was shuffled from hospital to hospital he sometimes wanted to die.

But now, Mario Bosco, 42, of Brooklyn, New York is a Hollywood actor and author whose rare illness that makes him look like a 14-year-old boy is the very thing that fuels his impressive career.

Bosco’s memoir entitled ‘From Hopeless to Hollywood: The Mario Bosco Story,’ which came out in July, details how panhypopituitarism, a condition caused by damage to his pituitary gland at birth, gave him the chance to play children on TV and in movies.

‘Life is tough but tomorrow is a surprise. Your dream is your friend and you have to believe in it to make it happen,’ Bosco told Dailymail.com of overcoming adversity to fulfill his lifelong dream of becoming an actor and writer.

Read the whole article here: Hollywood actor, 42, is trapped in a 14-year-old body and loves it

Filed under: Inspiration, pituitary | Tagged: , , , | Leave a comment »

Cushing’s Syndrome

Posted on October 3, 2015 by MaryO

The Seven Dwarves of Cushing's

 

Posted Oct. 1st, 2015 by Clare Rowson

Q: Would you please explain Cushing’s disease. How is it diagnosed? What are the symptoms?

A: Cushing syndrome results from excess levels of the hormone cortisol. It is produced in various glands, usually the adrenal that is situated above the kidneys on both sides, and the pituitary gland, which is in the centre of the brain.

Cortisol also regulates the way fats, carbohydrates and proteins are turned into usable forms of energy. These glands produce other hormones that affect things such as blood pressure and the body’s response to stress.

Cortisol may be added from outside the body by taking medications such as prednisone, often used for the control of chronic inflammatory or autoimmune diseases like lupus or rheumatoid arthritis.

Prednisone is also used for the treatment of acute illnesses such as severe allergies. Poison ivy is often treated this way.

Women in the last three months of pregnancy also have increased blood levels of cortisol and may temporarily display some of symptoms of Cushing’s syndrome.

Any problem with the pituitary gland, the nearby hypothalamus in the brain or adrenals can lead to Cushing’s syndrome. The most common is a benign tumour of the pituitary gland known as a pituitary adenoma.

This type of tumour may produce an excessive amount of a stimulating hormone known as ACTH, which in turn activates the hormones in the adrenal glands. On rare occasions, some types of lung or thyroid cancer can also behave in a similar way.

The most obvious sign of Cushing’s disease is marked weight gain, mostly in the abdomen, face and neck, while the arms and legs remain relatively thin.

As the skin in these areas becomes thinner, there may be purple coloured stripes or stretch marks. Women may also lose their periods and grow facial or body hair.

Blood pressure is usually high and sufferers feel weak and tired.

Cushing’s disease is diagnosed by measuring the amount of cortisol in a person’s urine during a 24 hour period.

If there is a tumour it will require surgical removal. If Cushing’s syndrome is a result of prescribed medication, the dosage can be reduced gradually or another type of medication can be tried. Prednisone must never be suddenly discontinued or the person’s blood pressure could drop dramatically, which could be serious and potentially fatal.

Clare Rowson is a retired medical doctor in Belleville, Ont. Contact: health@producer.com

From http://www.producer.com/2015/10/cushings-syndrome/

Filed under: adrenal, Cancer, Cushing's, pituitary | Tagged: , , , , , , , , , , | Leave a comment »

« Previous Page